J Korean Soc Microsurg.  2007 May;16(1):23-29.

Perforator-Based Fasciocutaneous Island Rotation Flap in Treatment of Pressure sore

Affiliations
  • 1Department of Plastic Surgery, Hanil General Hospital, Seoul, Korea.
  • 2Department of Plastic Surgery, Saeson Plastic Clinic, Daejeon, Korea. kwangps@naver.com

Abstract

The reconstruction of deep soft tissue defect such as pressure sore has difficult problems. Myocutaneous flaps have been used commonly as the best coverage method for pressure sore. But, they have several drawbacks such as sacrifice of functional muscle, high morbidity of the donor sites and bulkiness at the recipient site. The concepts of perforator flap has recently developed and widely used to overcome these disadvantages. Between March 2005 to July 2006, we have treated 9 patients who had pressure sore using perforator based fasciocutaneous island rotation flap. Preoperative unidirectional Doppler was used in all cases. Mean number of perforator vessels was 3.8 and flap sizes were from 7x5 cm to 14x13 cm. Rotation angles of flap were from 90 degree to 180 degree. In all cases, donor sites were closed primarily. All flap survived completely and postoperative complications were wound dehiscence in 1 case, wound infection in 3 cases. The mean postoperative follow up period was 15.7 months and recurrence was not reported. We could decrease donor site morbidity and cover wound sites easily by using flap rotation and get robust blood supply without sacrifice of functional muscle. Fasciocutaneous perforator island rotation flap would be very useful for various pressure sore treatment.

Keyword

Pressure sore; Surgical flap

MeSH Terms

Follow-Up Studies
Humans
Myocutaneous Flap
Perforator Flap
Postoperative Complications
Pressure Ulcer*
Recurrence
Surgical Flaps
Tissue Donors
Wound Infection
Wounds and Injuries
Full Text Links
  • JKSM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr